|
[1]陈灏珠, 林果为.实用内科学[M].第13版.北京:人民卫生出版社, 2009:1101-1106.
|
|
[2] 中华医学会肝病学分会、感染病分会.慢性乙型肝炎防治指南[J].中华肝脏病杂志, 2005, 13 (2) :881-891.
|
|
[3]唐平, 沈金红.肝病患者血小板计数及平均血小板体积的变化[J].海军医学杂志, 2009, 27 (2) :185.
|
|
[4]Ichino N, Osakabe K, Nishikawa T, et al.A new index for non-invasive assessment of liver fibrosis[J].World J Gastroenterol, 2010, 16 (38) :4809-4816.
|
|
[5]叶小净.肝炎肝硬化和重型肝炎患者血小板4项指标的测定意义[J].临床肝胆病杂志, 2007, 23 (2) :135-135.
|
|
[6]邓志凤, 赵椿.肝硬化、肝癌患者血小板参数纤维蛋白原及凝血酶原时间改变的临床意义[J].临床肝胆病杂志, 2007, 23 (5) :374-375.
|
|
[7]Tran A, Hastier P, Barjoan EM, et al.Noninvasive prediction ofsevere fibrosis in patients with alcoholic liver disease[J].Gastroen-terol Clin Biol, 2000, 24 (6-7) :626-630.
|
|
[8]Guechot J, Serfaty L, Bonnand AM, et al.Prognostic value of ser-um hyaluronan in patients with compensated HCV cirrhosis[J].JHepatol, 2000, 32 (3) :447-452.
|
|
[9]Rosenberg WM, Voelker M, Thiel R, et al.Serum markers detectthe presence of liver fibrosis:A cohort study[J].Gastroenterology, 2004, 127 (6) :1704-1713.
|
|
[10]Murawaki Y, Ikuta Y, Okamoto K, et al.Diagnostic value of serummarkers of connective tissue turnover for predicting histological stag-ing and grading in patients with chronic hepatitis C[J].J Gastroen-terol, 2001, 36 (6) :399-406.
|
|
[11]Swets JA.Measuring the accuracy of diagnostic systems[J].Sci-ence, 1988, 240 (4857) :1285-1293.
|
|
[12]何智敏.慢性乙肝患者血小板计数与慢性肝炎纤维化程度的相关性[J].现代预防医学, 2009, 36 (17) :3395-3397.
|
|
[13]陈永鹏, 冯筱榕, 吴爱华, 等.血清透明质酸联合血小板准确预测代偿性乙肝肝硬化[J].广东医学, 2009, 30 (2) :223-226.
|